|
|
Updated guidance to support countries in the development of National Immunization Strategies (NIS) is now available in English, French and Russian at https://www.who.int/teams/immunization-vaccines-and-biologicals/vaccine-access/planning-and-financing/nis.
The Guidance is accompanied by a new and simplified costing approach to support the NIS process, NIS.COST https://immunizationeconomics.org/unicef-niscost,
as well as guidance on Annual Operational Planning (AOPs).
The new NIS guidance focuses on more informed, country owned, and sustainable decision-making and the prioritization of interventions needed to reach zero dose children and communities in line with Immunization Agenda 2030. It also supports a dialogue between
Ministry of Health and Finance leads to ensure an agreed financial envelope is available to fund NIS key strategic priorities. In addition, there is greater emphasis on a broad and inclusive dialogue at the country level and greater integration with the health
care system beyond immunization.
This second webinar in a series will provide an introduction to NIS.COST is a new approach developed by UNICEF for estimating the costs and budget implications of implementing a five-year National Immunization Strategy.
Please join us for a webinar:
Feb 8 from 10am CET: translated into French
Feb 10 from 4pm CET: translated into French and Spanish
https://who.zoom.us/webinar/register/WN_XA1m2aopSX6duZeA5IEolA
|
|
|
|
|
|
Dear Maricel
Thank you for this interesting tool.
The 2021 CCE Gap Analysis Tool version includes a tab for PQEqpt (WHO PQS Prequalified equipment) that contains much of the product information for specific equipment that is developed
when that equipment undergoes prequalification PQS protocols. The tool (2019, 2021) took it a step further by combining this info into energy consumption indicators based on volumes (e.g. daily watt hour per net liters of vaccine storage and/or per liters
(kg) of water pack freezing capacity).
This is a useful approach to compare the electricity consumption of mains powered appliances on a fair basis since all prequaified appliances must pass the same rigor where both
their volume(s) and electrcity consumption is established through identical protocols carried out at WHO accredited test labs.
I recommend that this same set of indicators be continually supported by WHO in order for stakeholders to have one more way to consider environmental impacts of cold chain equipment
selections.
Respectfully submitted
Steve McCarney
Sunny Day LLC
|
|
|
|
|
|
Dear Maricel,
I would like to understand if countries can start using the new cold chain inventory tool? Ministry of Health needs to update the national cold chain equipment inventory so they
are interested in using the new tool. If so please share the tool.
Regards
Thato
|
|
|
|
|
|
Updated speaker list: Richard A. Adegbola, Pedro Alonso, Ashley Birkett, Simon Draper, Mary Hamel, David C. Kaslow, Kim Lee Sim, Rose Leke, Krishnamohan Bharat Mohan, Nicaise Ndembi,
Kate O'Brien, Deepali Patel, Regina Rabinovich, Umesh Shaligram and An Vermeersch.
|
|
|
|
|
|
|
|
Register now to join thought leaders from GSK, ISGlobal, Oxford University, PATH, Sanaria, WHO, and other institutions in a discussion of:
-
Lessons Learned from a Vaccine without a Dual Market -- from RTS,S Research and Development to Implementation and Distribution
-
Future Malaria Vaccine R&D Consideration
See the announcement for more details and links for agenda and registration.
|
|
|
|
|
|
|
|
|
|
|
Background document on the Novavax (NVX-CoV2373) vaccine against COVID-19
|
Author: World Health Organization
|
Published: 2021
|
Link:
View
|
|
|
|
Guidelines for developing a national immunization strategy: frequently asked questions, key concepts and terms
|
Author: World Health Organization
|
Published: 2021
|
Link:
View
|
|
|
|
Directives relatives à la microplanification opérationnelle de la vaccination contre la COVID-19
|
Author: Organisation Mondiale de la Santé (OMS)
|
Published: 2021
|
Link:
View
|
|
|
|
Malaria Vaccine R&D and Immunization: Lessons Learned and Considerations for Global Health Impact - 3 March 2022 - ANNOUNCEMENT
|
Author: GVIRF Secretariat
|
Published: 2021
|
Link:
View
|
|
|
|
Recommandations provisoires pour l’utilisation du vaccin Novavax NVX-CoV2373 contre la COVID-19 : orientations provisoires, 20 décembre 2021
|
Author: Organisation Mondiale de la Santé (OMS)
|
Published: 2021
|
Link:
View
|
|
|
|
|
|
|
|
|
Practical Applications For Data Triangulation in Immunization Supply Chain Management (Part 2 of a Two-Part Webinar, co-created and presented with VillageReach)
01st Feb 2022 1:00PM - 30th Nov -0001 12:00AM
|
|
|
|
New Webinar: Estimating the costs of a National Immunization Strategy (NIS)
08th Feb 2022 9:00AM - 08th Feb 2022 10:00AM
|
|
|
|
Cours en ligne CAC 1: chaîne d’approvisionnement pour la santé
20th Feb 2022 6:30PM - 21st Mar 2022 6:29PM
|
|
|
|
|
|
|
|
Temporary Appointment: Health Officer (Vaccine Management) (NO-2) - UNICEF, Afghanistan
|
Organization: UNICEF
|
Location: Afghanistan
|
Deadline: 01 February 2022
|
Website:
View
|
|
|
Roster of Consultants - Clinical and Quality Assessment of vaccines for Prequalification and Emergency Use Listing - WHO, Remote
|
Organization: WHO
|
Location: Remote
|
Deadline: 01 February 2022
|
Website:
View
|
|
|
Temporary Program Officer - PATH, Kenya
|
Organization: PATH
|
Location: Kenya
|
Deadline: 28 February 2022
|
Website:
View
|
|
|
Program Officer, Technology, Research and Analytics - Bill and Melinda Gates Foundation, United States
|
Organization: Bill and Melinda Gates Foundation
|
Location: United States
|
Deadline: 28 February 2022
|
Website:
View
|
|
|
Manager/Senior Manager, Applied Epidemiology - Sabin Vaccine Institute, United States
|
Organization: Sabin Vaccine Institute
|
Location: United States
|
Deadline: 28 February 2022
|
Website:
View
|
|
|
|
|
|
|
WORLD HEALTH ORGANIZATION_WER No. 04, 2022 / ORGANISATION MONDIALE DE LA SANTE_REH No. 04, 2022
|
|
|
Weekly epidemiological record
|
|
|
|
|
|
Moving the Needle: January 2022 news from PATH on vaccine development
News from PATH on vaccine development
|
|
|
GNN monthly update: January' 22
|
|
|
|
|
|
You have received this email because you are signed up to the TechNet-21 Weekly Digest.
Unsubscribe
|
|
|